Global Helicobacter Pylori Infection Treatment Market Growth (Status and Outlook) 2026-2032
The global Helicobacter Pylori Infection Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
United States market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Helicobacter Pylori Infection Treatment players cover Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Helicobacter Pylori Infection Treatment Industry Forecast? looks at past sales and reviews total world Helicobacter Pylori Infection Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Infection Treatment sales for 2026 through 2032. With Helicobacter Pylori Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Helicobacter Pylori Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Helicobacter Pylori Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Infection Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Infection Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
The Helicobacter pylori (H. pylori) treatment market refers to the market for drugs and therapies used to treat infections caused by the bacteria Helicobacter pylori. H. pylori is a common bacterium that infects the stomach lining and can lead to various gastrointestinal conditions such as gastritis, peptic ulcers, and stomach cancer.
The H. pylori treatment market is significant due to the prevalence of H. pylori infections worldwide and the potential complications associated with untreated infections. Treatment options typically involve a combination of antibiotics, proton pump inhibitors (PPIs), and other medications to eradicate the bacteria and heal the affected tissues.
The market for H. pylori treatment includes various pharmaceutical companies that develop and manufacture antibiotics and PPIs, as well as other healthcare providers involved in diagnosing and treating H. pylori infections. These companies compete to provide effective and safe treatment options and may also invest in research and development to improve therapeutic approaches.
United States market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Helicobacter Pylori Infection Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Helicobacter Pylori Infection Treatment players cover Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Helicobacter Pylori Infection Treatment Industry Forecast? looks at past sales and reviews total world Helicobacter Pylori Infection Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Helicobacter Pylori Infection Treatment sales for 2026 through 2032. With Helicobacter Pylori Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Helicobacter Pylori Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Helicobacter Pylori Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Helicobacter Pylori Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Helicobacter Pylori Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Helicobacter Pylori Infection Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Helicobacter Pylori Infection Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Helicobacter Pylori Infection Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Bismuth-quadruple Therapy
- Concomitant Therapy
- Levofloxacin Triple Therapy
- Bismuth Therapy
- High-dose Dual Therapy
- Hospitals
- Diagnostics Laboratories
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cumberland Pharmaceuticals
- Eisai Co.
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Alpha Laboratories
- Biohit
- Phathom Pharmaceuticals
- Redhill Biopharma
- Takeda Pharmaceuticals
- AbbVie
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Helicobacter Pylori Infection Treatment Market Size (2021-2032)
2.1.2 Helicobacter Pylori Infection Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Helicobacter Pylori Infection Treatment by Country/Region (2021, 2025 & 2032)
2.2 Helicobacter Pylori Infection Treatment Segment by Type
2.2.1 Bismuth-quadruple Therapy
2.2.2 Concomitant Therapy
2.2.3 Levofloxacin Triple Therapy
2.2.4 Bismuth Therapy
2.2.5 High-dose Dual Therapy
2.2.6 Helicobacter Pylori Infection Treatment Market Size by Type
2.2.6.1 Helicobacter Pylori Infection Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
2.3 Helicobacter Pylori Infection Treatment Segment by Application
2.3.1 Hospitals
2.3.2 Diagnostics Laboratories
2.3.3 Clinics
2.3.4 Helicobacter Pylori Infection Treatment Market Size by Application
2.3.4.1 Helicobacter Pylori Infection Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
3 HELICOBACTER PYLORI INFECTION TREATMENT MARKET SIZE BY PLAYER
3.1 Helicobacter Pylori Infection Treatment Market Size Market Share by Player
3.1.1 Global Helicobacter Pylori Infection Treatment Revenue by Player (2021-2026)
3.1.2 Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Helicobacter Pylori Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HELICOBACTER PYLORI INFECTION TREATMENT BY REGION
4.1 Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
4.2 Global Helicobacter Pylori Infection Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.4 APAC Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.5 Europe Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
5.2 Americas Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
5.3 Americas Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
6.2 APAC Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
6.3 APAC Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
7.2 Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
7.3 Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Helicobacter Pylori Infection Treatment by Region (2021-2026)
8.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HELICOBACTER PYLORI INFECTION TREATMENT MARKET FORECAST
10.1 Global Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.1.1 Global Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.1.2 Americas Helicobacter Pylori Infection Treatment Forecast
10.1.3 APAC Helicobacter Pylori Infection Treatment Forecast
10.1.4 Europe Helicobacter Pylori Infection Treatment Forecast
10.1.5 Middle East & Africa Helicobacter Pylori Infection Treatment Forecast
10.2 Americas Helicobacter Pylori Infection Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Helicobacter Pylori Infection Treatment Forecast
10.2.2 Canada Market Helicobacter Pylori Infection Treatment Forecast
10.2.3 Mexico Market Helicobacter Pylori Infection Treatment Forecast
10.2.4 Brazil Market Helicobacter Pylori Infection Treatment Forecast
10.3 APAC Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.3.1 China Helicobacter Pylori Infection Treatment Market Forecast
10.3.2 Japan Market Helicobacter Pylori Infection Treatment Forecast
10.3.3 Korea Market Helicobacter Pylori Infection Treatment Forecast
10.3.4 Southeast Asia Market Helicobacter Pylori Infection Treatment Forecast
10.3.5 India Market Helicobacter Pylori Infection Treatment Forecast
10.3.6 Australia Market Helicobacter Pylori Infection Treatment Forecast
10.4 Europe Helicobacter Pylori Infection Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Helicobacter Pylori Infection Treatment Forecast
10.4.2 France Market Helicobacter Pylori Infection Treatment Forecast
10.4.3 UK Market Helicobacter Pylori Infection Treatment Forecast
10.4.4 Italy Market Helicobacter Pylori Infection Treatment Forecast
10.4.5 Russia Market Helicobacter Pylori Infection Treatment Forecast
10.5 Middle East & Africa Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Helicobacter Pylori Infection Treatment Forecast
10.5.2 South Africa Market Helicobacter Pylori Infection Treatment Forecast
10.5.3 Israel Market Helicobacter Pylori Infection Treatment Forecast
10.5.4 Turkey Market Helicobacter Pylori Infection Treatment Forecast
10.6 Global Helicobacter Pylori Infection Treatment Forecast by Type (2027-2032)
10.7 Global Helicobacter Pylori Infection Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Helicobacter Pylori Infection Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Company Information
11.1.2 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cumberland Pharmaceuticals Main Business Overview
11.1.5 Cumberland Pharmaceuticals Latest Developments
11.2 Eisai Co.
11.2.1 Eisai Co. Company Information
11.2.2 Eisai Co. Helicobacter Pylori Infection Treatment Product Offered
11.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eisai Co. Main Business Overview
11.2.5 Eisai Co. Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Offered
11.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Offered
11.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche Main Business Overview
11.4.5 F. Hoffmann-La Roche Latest Developments
11.5 Alpha Laboratories
11.5.1 Alpha Laboratories Company Information
11.5.2 Alpha Laboratories Helicobacter Pylori Infection Treatment Product Offered
11.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alpha Laboratories Main Business Overview
11.5.5 Alpha Laboratories Latest Developments
11.6 Biohit
11.6.1 Biohit Company Information
11.6.2 Biohit Helicobacter Pylori Infection Treatment Product Offered
11.6.3 Biohit Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biohit Main Business Overview
11.6.5 Biohit Latest Developments
11.7 Phathom Pharmaceuticals
11.7.1 Phathom Pharmaceuticals Company Information
11.7.2 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Phathom Pharmaceuticals Main Business Overview
11.7.5 Phathom Pharmaceuticals Latest Developments
11.8 Redhill Biopharma
11.8.1 Redhill Biopharma Company Information
11.8.2 Redhill Biopharma Helicobacter Pylori Infection Treatment Product Offered
11.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Redhill Biopharma Main Business Overview
11.8.5 Redhill Biopharma Latest Developments
11.9 Takeda Pharmaceuticals
11.9.1 Takeda Pharmaceuticals Company Information
11.9.2 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Takeda Pharmaceuticals Main Business Overview
11.9.5 Takeda Pharmaceuticals Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Helicobacter Pylori Infection Treatment Product Offered
11.10.3 AbbVie Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Helicobacter Pylori Infection Treatment Market Size (2021-2032)
2.1.2 Helicobacter Pylori Infection Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Helicobacter Pylori Infection Treatment by Country/Region (2021, 2025 & 2032)
2.2 Helicobacter Pylori Infection Treatment Segment by Type
2.2.1 Bismuth-quadruple Therapy
2.2.2 Concomitant Therapy
2.2.3 Levofloxacin Triple Therapy
2.2.4 Bismuth Therapy
2.2.5 High-dose Dual Therapy
2.2.6 Helicobacter Pylori Infection Treatment Market Size by Type
2.2.6.1 Helicobacter Pylori Infection Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
2.3 Helicobacter Pylori Infection Treatment Segment by Application
2.3.1 Hospitals
2.3.2 Diagnostics Laboratories
2.3.3 Clinics
2.3.4 Helicobacter Pylori Infection Treatment Market Size by Application
2.3.4.1 Helicobacter Pylori Infection Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
3 HELICOBACTER PYLORI INFECTION TREATMENT MARKET SIZE BY PLAYER
3.1 Helicobacter Pylori Infection Treatment Market Size Market Share by Player
3.1.1 Global Helicobacter Pylori Infection Treatment Revenue by Player (2021-2026)
3.1.2 Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Helicobacter Pylori Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HELICOBACTER PYLORI INFECTION TREATMENT BY REGION
4.1 Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
4.2 Global Helicobacter Pylori Infection Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.4 APAC Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.5 Europe Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
5.2 Americas Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
5.3 Americas Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
6.2 APAC Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
6.3 APAC Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
7.2 Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
7.3 Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Helicobacter Pylori Infection Treatment by Region (2021-2026)
8.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HELICOBACTER PYLORI INFECTION TREATMENT MARKET FORECAST
10.1 Global Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.1.1 Global Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.1.2 Americas Helicobacter Pylori Infection Treatment Forecast
10.1.3 APAC Helicobacter Pylori Infection Treatment Forecast
10.1.4 Europe Helicobacter Pylori Infection Treatment Forecast
10.1.5 Middle East & Africa Helicobacter Pylori Infection Treatment Forecast
10.2 Americas Helicobacter Pylori Infection Treatment Forecast by Country (2027-2032)
10.2.1 United States Market Helicobacter Pylori Infection Treatment Forecast
10.2.2 Canada Market Helicobacter Pylori Infection Treatment Forecast
10.2.3 Mexico Market Helicobacter Pylori Infection Treatment Forecast
10.2.4 Brazil Market Helicobacter Pylori Infection Treatment Forecast
10.3 APAC Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.3.1 China Helicobacter Pylori Infection Treatment Market Forecast
10.3.2 Japan Market Helicobacter Pylori Infection Treatment Forecast
10.3.3 Korea Market Helicobacter Pylori Infection Treatment Forecast
10.3.4 Southeast Asia Market Helicobacter Pylori Infection Treatment Forecast
10.3.5 India Market Helicobacter Pylori Infection Treatment Forecast
10.3.6 Australia Market Helicobacter Pylori Infection Treatment Forecast
10.4 Europe Helicobacter Pylori Infection Treatment Forecast by Country (2027-2032)
10.4.1 Germany Market Helicobacter Pylori Infection Treatment Forecast
10.4.2 France Market Helicobacter Pylori Infection Treatment Forecast
10.4.3 UK Market Helicobacter Pylori Infection Treatment Forecast
10.4.4 Italy Market Helicobacter Pylori Infection Treatment Forecast
10.4.5 Russia Market Helicobacter Pylori Infection Treatment Forecast
10.5 Middle East & Africa Helicobacter Pylori Infection Treatment Forecast by Region (2027-2032)
10.5.1 Egypt Market Helicobacter Pylori Infection Treatment Forecast
10.5.2 South Africa Market Helicobacter Pylori Infection Treatment Forecast
10.5.3 Israel Market Helicobacter Pylori Infection Treatment Forecast
10.5.4 Turkey Market Helicobacter Pylori Infection Treatment Forecast
10.6 Global Helicobacter Pylori Infection Treatment Forecast by Type (2027-2032)
10.7 Global Helicobacter Pylori Infection Treatment Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Helicobacter Pylori Infection Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Company Information
11.1.2 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cumberland Pharmaceuticals Main Business Overview
11.1.5 Cumberland Pharmaceuticals Latest Developments
11.2 Eisai Co.
11.2.1 Eisai Co. Company Information
11.2.2 Eisai Co. Helicobacter Pylori Infection Treatment Product Offered
11.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Eisai Co. Main Business Overview
11.2.5 Eisai Co. Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Offered
11.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Offered
11.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 F. Hoffmann-La Roche Main Business Overview
11.4.5 F. Hoffmann-La Roche Latest Developments
11.5 Alpha Laboratories
11.5.1 Alpha Laboratories Company Information
11.5.2 Alpha Laboratories Helicobacter Pylori Infection Treatment Product Offered
11.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Alpha Laboratories Main Business Overview
11.5.5 Alpha Laboratories Latest Developments
11.6 Biohit
11.6.1 Biohit Company Information
11.6.2 Biohit Helicobacter Pylori Infection Treatment Product Offered
11.6.3 Biohit Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biohit Main Business Overview
11.6.5 Biohit Latest Developments
11.7 Phathom Pharmaceuticals
11.7.1 Phathom Pharmaceuticals Company Information
11.7.2 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Phathom Pharmaceuticals Main Business Overview
11.7.5 Phathom Pharmaceuticals Latest Developments
11.8 Redhill Biopharma
11.8.1 Redhill Biopharma Company Information
11.8.2 Redhill Biopharma Helicobacter Pylori Infection Treatment Product Offered
11.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Redhill Biopharma Main Business Overview
11.8.5 Redhill Biopharma Latest Developments
11.9 Takeda Pharmaceuticals
11.9.1 Takeda Pharmaceuticals Company Information
11.9.2 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
11.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Takeda Pharmaceuticals Main Business Overview
11.9.5 Takeda Pharmaceuticals Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Helicobacter Pylori Infection Treatment Product Offered
11.10.3 AbbVie Helicobacter Pylori Infection Treatment Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Helicobacter Pylori Infection Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Helicobacter Pylori Infection Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bismuth-quadruple Therapy
Table 4. Major Players of Concomitant Therapy
Table 5. Major Players of Levofloxacin Triple Therapy
Table 6. Major Players of Bismuth Therapy
Table 7. Major Players of High-dose Dual Therapy
Table 8. Helicobacter Pylori Infection Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Table 11. Helicobacter Pylori Infection Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Table 14. Global Helicobacter Pylori Infection Treatment Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player (2021-2026)
Table 16. Helicobacter Pylori Infection Treatment Key Players Head office and Products Offered
Table 17. Helicobacter Pylori Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Table 22. Global Helicobacter Pylori Infection Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Country (2021-2026)
Table 26. Americas Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Table 28. Americas Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Table 30. APAC Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Table 32. APAC Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Country (2021-2026)
Table 36. Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Helicobacter Pylori Infection Treatment
Table 42. Key Market Challenges & Risks of Helicobacter Pylori Infection Treatment
Table 43. Key Industry Trends of Helicobacter Pylori Infection Treatment
Table 44. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Cumberland Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 49. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 50. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Cumberland Pharmaceuticals Main Business
Table 52. Cumberland Pharmaceuticals Latest Developments
Table 53. Eisai Co. Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 54. Eisai Co. Helicobacter Pylori Infection Treatment Product Offered
Table 55. Eisai Co. Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Eisai Co. Main Business
Table 57. Eisai Co. Latest Developments
Table 58. Bio-Rad Laboratories Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 59. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Offered
Table 60. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Bio-Rad Laboratories Main Business
Table 62. Bio-Rad Laboratories Latest Developments
Table 63. F. Hoffmann-La Roche Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 64. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Offered
Table 65. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. F. Hoffmann-La Roche Main Business
Table 67. F. Hoffmann-La Roche Latest Developments
Table 68. Alpha Laboratories Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 69. Alpha Laboratories Helicobacter Pylori Infection Treatment Product Offered
Table 70. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Alpha Laboratories Main Business
Table 72. Alpha Laboratories Latest Developments
Table 73. Biohit Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 74. Biohit Helicobacter Pylori Infection Treatment Product Offered
Table 75. Biohit Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Biohit Main Business
Table 77. Biohit Latest Developments
Table 78. Phathom Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 79. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 80. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Phathom Pharmaceuticals Main Business
Table 82. Phathom Pharmaceuticals Latest Developments
Table 83. Redhill Biopharma Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 84. Redhill Biopharma Helicobacter Pylori Infection Treatment Product Offered
Table 85. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Redhill Biopharma Main Business
Table 87. Redhill Biopharma Latest Developments
Table 88. Takeda Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 89. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 90. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Takeda Pharmaceuticals Main Business
Table 92. Takeda Pharmaceuticals Latest Developments
Table 93. AbbVie Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 94. AbbVie Helicobacter Pylori Infection Treatment Product Offered
Table 95. AbbVie Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. AbbVie Main Business
Table 97. AbbVie Latest Developments
Table 1. Helicobacter Pylori Infection Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Helicobacter Pylori Infection Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Bismuth-quadruple Therapy
Table 4. Major Players of Concomitant Therapy
Table 5. Major Players of Levofloxacin Triple Therapy
Table 6. Major Players of Bismuth Therapy
Table 7. Major Players of High-dose Dual Therapy
Table 8. Helicobacter Pylori Infection Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Table 11. Helicobacter Pylori Infection Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Table 14. Global Helicobacter Pylori Infection Treatment Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player (2021-2026)
Table 16. Helicobacter Pylori Infection Treatment Key Players Head office and Products Offered
Table 17. Helicobacter Pylori Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Table 22. Global Helicobacter Pylori Infection Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Country (2021-2026)
Table 26. Americas Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Table 28. Americas Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Table 30. APAC Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Table 32. APAC Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Country (2021-2026)
Table 36. Europe Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Helicobacter Pylori Infection Treatment
Table 42. Key Market Challenges & Risks of Helicobacter Pylori Infection Treatment
Table 43. Key Industry Trends of Helicobacter Pylori Infection Treatment
Table 44. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Helicobacter Pylori Infection Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Cumberland Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 49. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 50. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Cumberland Pharmaceuticals Main Business
Table 52. Cumberland Pharmaceuticals Latest Developments
Table 53. Eisai Co. Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 54. Eisai Co. Helicobacter Pylori Infection Treatment Product Offered
Table 55. Eisai Co. Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Eisai Co. Main Business
Table 57. Eisai Co. Latest Developments
Table 58. Bio-Rad Laboratories Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 59. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Offered
Table 60. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Bio-Rad Laboratories Main Business
Table 62. Bio-Rad Laboratories Latest Developments
Table 63. F. Hoffmann-La Roche Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 64. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Offered
Table 65. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. F. Hoffmann-La Roche Main Business
Table 67. F. Hoffmann-La Roche Latest Developments
Table 68. Alpha Laboratories Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 69. Alpha Laboratories Helicobacter Pylori Infection Treatment Product Offered
Table 70. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Alpha Laboratories Main Business
Table 72. Alpha Laboratories Latest Developments
Table 73. Biohit Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 74. Biohit Helicobacter Pylori Infection Treatment Product Offered
Table 75. Biohit Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Biohit Main Business
Table 77. Biohit Latest Developments
Table 78. Phathom Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 79. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 80. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Phathom Pharmaceuticals Main Business
Table 82. Phathom Pharmaceuticals Latest Developments
Table 83. Redhill Biopharma Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 84. Redhill Biopharma Helicobacter Pylori Infection Treatment Product Offered
Table 85. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Redhill Biopharma Main Business
Table 87. Redhill Biopharma Latest Developments
Table 88. Takeda Pharmaceuticals Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 89. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Offered
Table 90. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Takeda Pharmaceuticals Main Business
Table 92. Takeda Pharmaceuticals Latest Developments
Table 93. AbbVie Details, Company Type, Helicobacter Pylori Infection Treatment Area Served and Its Competitors
Table 94. AbbVie Helicobacter Pylori Infection Treatment Product Offered
Table 95. AbbVie Helicobacter Pylori Infection Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. AbbVie Main Business
Table 97. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Helicobacter Pylori Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Helicobacter Pylori Infection Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Helicobacter Pylori Infection Treatment Sales Market Share by Country/Region (2025)
Figure 8. Helicobacter Pylori Infection Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type in 2025
Figure 10. Helicobacter Pylori Infection Treatment in Hospitals
Figure 11. Global Helicobacter Pylori Infection Treatment Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Helicobacter Pylori Infection Treatment in Diagnostics Laboratories
Figure 13. Global Helicobacter Pylori Infection Treatment Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 14. Helicobacter Pylori Infection Treatment in Clinics
Figure 15. Global Helicobacter Pylori Infection Treatment Market: Clinics (2021-2026) & ($ millions)
Figure 16. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application in 2025
Figure 17. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player in 2025
Figure 18. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Helicobacter Pylori Infection Treatment Value Market Share by Country in 2025
Figure 24. United States Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 1. Helicobacter Pylori Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Helicobacter Pylori Infection Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Helicobacter Pylori Infection Treatment Sales Market Share by Country/Region (2025)
Figure 8. Helicobacter Pylori Infection Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Type in 2025
Figure 10. Helicobacter Pylori Infection Treatment in Hospitals
Figure 11. Global Helicobacter Pylori Infection Treatment Market: Hospitals (2021-2026) & ($ millions)
Figure 12. Helicobacter Pylori Infection Treatment in Diagnostics Laboratories
Figure 13. Global Helicobacter Pylori Infection Treatment Market: Diagnostics Laboratories (2021-2026) & ($ millions)
Figure 14. Helicobacter Pylori Infection Treatment in Clinics
Figure 15. Global Helicobacter Pylori Infection Treatment Market: Clinics (2021-2026) & ($ millions)
Figure 16. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Application in 2025
Figure 17. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Player in 2025
Figure 18. Global Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Helicobacter Pylori Infection Treatment Value Market Share by Country in 2025
Figure 24. United States Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Helicobacter Pylori Infection Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Helicobacter Pylori Infection Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Helicobacter Pylori Infection Treatment Market Size 2027-2032 ($ millions)
